Liver transplantation in the human immunodeficiency virus-hepatitis C virus coinfected patient: Time to sum up

Hepatology

Volumn 57, Issue 1, 2013, Pages 409-411

  Samuel, Didier ^a,b,c   Duclos Vallee, Jean Charles ^a,b,c  

^a HÔPITAL PAUL BROUSSE   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CALCINEURIN INHIBITOR; NUCLEOTIDE DERIVATIVE; PROTEINASE INHIBITOR;

ACUTE GRAFT REJECTION; BODY MASS; COHORT ANALYSIS; DISEASE SEVERITY; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MIXED INFECTION; NOTE; ORGAN DONOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS LOAD;

EID: 84872158985     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26123     Document Type: Note

References (11)

1. Consensus Conference: indications for liver transplantation, January 19 and 20, 2005, Lyon-Palais des Congrès: text of recommendations (long version). Liver Transplant 2006; 12: 998-1011.
2. Samuel D, Weber R, Stock P, Duclos-Vallee JC, Terrault N. Are HIV infected patients candidates for liver transplantation? J Hepatol 2008; 48: 697-707
3. Terrault N, Carter JT, Carlson L, Roland ME, Stock PG. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transplant 2006; 12: 801-807.
4. Tateo M, Roque-Afonso AM, Antonini TM, Medja F, Lombes A, Jardel C, et al. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity. AIDS 2009; 23: 1069-1076.
5. Duclos-Vallee JC, Feray C, Sebagh M, Teicher E, Roque-Afonso AM, Roche B, et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. HEPATOLOGY 2008; 47: 407-417.
6. De Vera ME, Dvorchik I, Tom K, Eghtesad B, Thai N, Shakil O, et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transpl 2006; 6: 2983-2993.
7. Samri A, Roque-Afonso AM, Beran O, Tateo M, Teicher, Feray C, et al. Preservation of immune function and anti-hepatitis C virus (HCV) immune response after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC " trial). J Hepatol 2009; 51: 1000-1009.
8. Antonini TM, Sebagh M, Roque-Afonso AM, Teicher E, Roche B, Sobesky R, et al. Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantation. Am J Transplant 2011; 11: 1686-1695.
9. Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, et al. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transplant 2012; 18: 716-726.
10. Miro JM, Montajo M, Rafecas A, Moreno S, Aguero F, Abradelo M, et al. Outcome of HCV/HIV coinfected liver transplant recipients: a prospective and multicenter cohort study. Am J Transplant 2012; 12: 1866-1876.
11. Coilly A, Roche B, Botta-Fridlund D, Leroy V, Pageaux PG, Si-Ahmed SN, et al. Efficacy and safety of protease inhibitors for severe hepatitis C recurrence after liver transplantation: a first multicentric experience. J Hepatol 2012; 56( Suppl. 2): S21.